Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKAG1 | P54619 | 17/20 | 0.53 |
| ▸ | PRKAA2 | P54646 | 17/20 | 0.53 |
| ▸ | PRKAB1 | Q9Y478 | 17/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18818128 | 0.86 | PRKAG1 (0.56) | PRKAG1PRKAA2PRKAB1 | |
| Bryogenin SCHEMBL30023603 | 0.86 | PRKAG1 (0.51) | PRKAG1PRKAA2PRKAB1 | |
| SCHEMBL18805316 | 0.85 | PRKAG1 (0.60) | PRKAG1PRKAA2PRKAB1 | |
| Bryodulcosigenin SCHEMBL18805155 | 0.84 | PRKAG1 (0.71) | PRKAG1PRKAA2PRKAB1 | |
| SCHEMBL19423485 | 0.83 | PRKAG1 (0.56) | PRKAG1PRKAA2PRKAB1PTGES | |
| SCHEMBL30222239 | 0.83 | PRKAG1 (0.56) | PRKAG1PRKAA2PRKAB1PTGES | |
| SCHEMBL29825906 | 0.83 | PRKAG1 (0.56) | PRKAG1PRKAA2PRKAB1PTGES | |
| SCHEMBL19423484 | 0.83 | PRKAG1 (0.75) | PRKAG1PRKAA2PRKAB1 | |
| SCHEMBL29825605 | 0.83 | PRKAG1 (0.75) | PRKAG1PRKAA2PRKAB1 | |
| SCHEMBL29356806 | 0.73 | CDC25B (0.67) | MAPK1PTGESFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025207298-A1 | MOGROSIDE COMPOSITIONS AND METHODS OF PRODUCING SAME | ELO LIFE SYSTEMS (US) | 2025-10-02 | — | — | WO | disclosed |
| EP-4590847-A2 | MOGROSIDE COMPOSITIONS AND METHODS OF PRODUCING SAME | ELO Life Systems (US) | 2025-07-30 | — | — | EP | disclosed |
| WO-2024064695-A2 | MOGROSIDE COMPOSITIONS AND METHODS OF PRODUCING SAME | ELO LIFE SYSTEMS (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024059517-A1 | BIOSYNTHESIS OF OXYGENATED HYDROCARBONS | GINKGO BIOWORKS, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-4314271-A1 | BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF | Ginkgo Bioworks, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4314272-A1 | BIOSYNTHESIS OF MOGROSIDES | Ginkgo Bioworks, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4120823-A1 | NOVEL MOGROSIDE PRODUCTION SYSTEM AND METHODS | The Coca-Cola Company (US) | 2023-01-25 | — | — | EP | disclosed |
| WO-2022212917-A1 | BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF | GINKGO BIOWORKS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022212924-A1 | BIOSYNTHESIS OF MOGROSIDES | GINKGO BIOWORKS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |